Repeated Bout Effect i Neuromuscular Diseases
1 other identifier
interventional
50
1 country
1
Brief Summary
The repeated bout effect (RBE) refers to the adaptation whereby a single bout of eccentric exercise protects against muscle damage from subsequent eccentric bouts. This effect has been shown in many muscle groups using both serum biomarkers, muscle soreness and imaging techniques. Though the effect is well described in healthy, it has never been studied in patients with neuromuscular diseases (NMDs). In healthy, the RBE is only described using eccentric exercise, but unlike healthy persons, patients with NMDs can experience significant muscle damage with concentric exercise. This raises the question, if patients with NMDs could also show RBE when performing concentric exercise.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 15, 2022
CompletedFirst Submitted
Initial submission to the registry
October 26, 2022
CompletedFirst Posted
Study publicly available on registry
October 31, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2026
ExpectedApril 6, 2025
April 1, 2025
3.6 years
October 26, 2022
April 2, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Delta CK
Change in peak kreatine kinase following first and second exercise bout.
1 month
Study Arms (1)
Exercise challenge
OTHERAt baseline, subjects will perform the selected exercise challenge followed by blood samples collected at rest and 0, 2, 4, 24 hours and 4 days after end of exercise. Muscle soreness will be measured by asking the participant how sore their muscles in their thighs are on a visual-analog scale (1-10) at the same timepoints. After 4 weeks (+/- 3 days) of normal daily activity, the same test will be performed including blood samples.
Interventions
Eligibility Criteria
You may qualify if:
- Age \> 18 years
- The ability to complete the exercise challenge
- No concurrent medical condition that could interfere with interpretation of the results
- Molecular diagnosis of the specific condition in specified patient groups or healthy control
- No active muscle injury on the test day (caused by recent exercise, seizures, trauma, etc.)
You may not qualify if:
- Cardiac or pulmonary disease contraindicating peak exercise testing or strenuous exercise defined as NYHA-class III-IV
- Veins that are too difficult to puncture for blood sampling, evaluated by the investigator
- Severe muscle weakness, that prevents the subject completing the exercise test, evaluated by the investigator
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Neuromuscular Research Unit, 3342
Copenhagen, DK-2100, Denmark
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Subinvestigator
Study Record Dates
First Submitted
October 26, 2022
First Posted
October 31, 2022
Study Start
May 15, 2022
Primary Completion
January 1, 2026
Study Completion (Estimated)
May 30, 2026
Last Updated
April 6, 2025
Record last verified: 2025-04